Endocrine 66 (2), 157165
In a recent clinical trial, adults with obesity (without diabetes) lost an average of 20.2% of their body weight with tirzepatide as compared to 13.7% with semaglutide over 72 weeks
A meta-analysis of 77 RCTs involving 50,820 patients with T2DM found that compared with placebo, lifestyle modification, or active anti-diabetic drugs, SGLT2is were associated with a significantly higher risk of genital infections (RR, 3.30
This suggested either the existence of an alternate receptor for GLP-1 and/or GLP-1(936), or receptor-independent mechanisms of action
This dual mechanism helps control food cravings, boosts blood sugar regulation, and extends digestion time, resulting in significant weight loss
Repeated injections into a lump can reduce insulin absorption